Shockwave Medical Stock Beta
| SWAVDelisted Stock | USD 268.45 6.44 2.34% |
Shockwave Medical fundamentals help investors to digest information that contributes to Shockwave Medical's financial success or failures. It also enables traders to predict the movement of Shockwave Stock. The fundamental analysis module provides a way to measure Shockwave Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Shockwave Medical stock.
Shockwave |
Shockwave Medical Company Beta Analysis
Shockwave Medical's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Shockwave Medical Beta | 0.88 |
Most of Shockwave Medical's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Shockwave Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CompetitionIn accordance with the recently published financial statements, Shockwave Medical has a Beta of 0.879. This is 2.21% higher than that of the Health Care Equipment & Supplies sector and 15.48% lower than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Shockwave Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Shockwave Medical's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Shockwave Medical could also be used in its relative valuation, which is a method of valuing Shockwave Medical by comparing valuation metrics of similar companies.Shockwave Medical is currently under evaluation in beta category among its peers.
Shockwave Medical returns are very sensitive to returns on the market. As the market goes up or down, Shockwave Medical is expected to follow.
Shockwave Fundamentals
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0868 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 12.32 B | |||
| Shares Outstanding | 37.54 M | |||
| Shares Owned By Insiders | 1.19 % | |||
| Shares Owned By Institutions | 98.72 % | |||
| Number Of Shares Shorted | 1.83 M | |||
| Price To Earning | 178.55 X | |||
| Price To Book | 18.38 X | |||
| Price To Sales | 16.83 X | |||
| Revenue | 730.23 M | |||
| Gross Profit | 424.74 M | |||
| EBITDA | 176.35 M | |||
| Net Income | 147.28 M | |||
| Cash And Equivalents | 224.91 M | |||
| Cash Per Share | 6.26 X | |||
| Total Debt | 770.61 M | |||
| Debt To Equity | 0.15 % | |||
| Current Ratio | 5.32 X | |||
| Book Value Per Share | 20.04 X | |||
| Cash Flow From Operations | 196.05 M | |||
| Short Ratio | 2.24 X | |||
| Earnings Per Share | 4.25 X | |||
| Price To Earnings To Growth | 1.38 X | |||
| Target Price | 324.27 | |||
| Number Of Employees | 1.47 K | |||
| Beta | 0.88 | |||
| Market Capitalization | 12.57 B | |||
| Total Asset | 1.57 B | |||
| Retained Earnings | 110.47 M | |||
| Working Capital | 1.12 B | |||
| Net Asset | 1.57 B |
About Shockwave Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Shockwave Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Shockwave Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Shockwave Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Shockwave Stock
If you are still planning to invest in Shockwave Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Shockwave Medical's history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stocks Directory Find actively traded stocks across global markets |